Promoting both quantity and quality of life, Part 2. Methodological Considerations for the Assessment of Health-Related Quality of Life (HRQoL) in Clinical Trials

Melanie Calvert; Nick Freemantle

doi:10.1046/j.0269-4727.2003.00520.x

Promoting both quantity and quality of life, Part 2. Methodological Considerations for the Assessment of Health-Related Quality of Life (HRQoL) in Clinical Trials

Melanie Calvert, Nick Freemantle

Research output: Contribution to journal › Article

18 Citations (Scopus)

Abstract

This article aims to address key methodological issues that should be considered when assessing health-related quality of life (HRQoL) in a clinical trial. These include justification for the selection of HRQoL as a primary or secondary outcome and choice of an appropriate instrument to assess HRQoL, which meets basic psychometric properties. In addition we consider ways to minimize bias within the trial through optimization of compliance and timing of assessments.

Original language	English
Pages (from-to)	85-94
Number of pages	10
Journal	Journal of Clinical Pharmacy and Therapeutics
Volume	29
Issue number	1
DOIs	https://doi.org/10.1046/j.0269-4727.2003.00520.x
Publication status	Published - 1 Jan 2004

Access to Document

10.1046/j.0269-4727.2003.00520.x

Cite this

@article{0b345d85e1c34c7198b211334ea45784,

title = "Promoting both quantity and quality of life, Part 2. Methodological Considerations for the Assessment of Health-Related Quality of Life (HRQoL) in Clinical Trials",

abstract = "This article aims to address key methodological issues that should be considered when assessing health-related quality of life (HRQoL) in a clinical trial. These include justification for the selection of HRQoL as a primary or secondary outcome and choice of an appropriate instrument to assess HRQoL, which meets basic psychometric properties. In addition we consider ways to minimize bias within the trial through optimization of compliance and timing of assessments.",

author = "Melanie Calvert and Nick Freemantle",

year = "2004",

month = jan,

day = "1",

doi = "10.1046/j.0269-4727.2003.00520.x",

language = "English",

volume = "29",

pages = "85--94",

journal = "Journal of Clinical Pharmacy and Therapeutics",

issn = "1365-2710",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Promoting both quantity and quality of life, Part 2. Methodological Considerations for the Assessment of Health-Related Quality of Life (HRQoL) in Clinical Trials

AU - Calvert, Melanie

AU - Freemantle, Nick

PY - 2004/1/1

Y1 - 2004/1/1

N2 - This article aims to address key methodological issues that should be considered when assessing health-related quality of life (HRQoL) in a clinical trial. These include justification for the selection of HRQoL as a primary or secondary outcome and choice of an appropriate instrument to assess HRQoL, which meets basic psychometric properties. In addition we consider ways to minimize bias within the trial through optimization of compliance and timing of assessments.

AB - This article aims to address key methodological issues that should be considered when assessing health-related quality of life (HRQoL) in a clinical trial. These include justification for the selection of HRQoL as a primary or secondary outcome and choice of an appropriate instrument to assess HRQoL, which meets basic psychometric properties. In addition we consider ways to minimize bias within the trial through optimization of compliance and timing of assessments.

UR - https://www.scopus.com/pages/publications/1342331445

U2 - 10.1046/j.0269-4727.2003.00520.x

DO - 10.1046/j.0269-4727.2003.00520.x

M3 - Article

C2 - 14748903

SN - 1365-2710

VL - 29

SP - 85

EP - 94

JO - Journal of Clinical Pharmacy and Therapeutics

JF - Journal of Clinical Pharmacy and Therapeutics

IS - 1

ER -

Promoting both quantity and quality of life, Part 2. Methodological Considerations for the Assessment of Health-Related Quality of Life (HRQoL) in Clinical Trials

Abstract

Access to Document

Fingerprint

Cite this